JanePTF has an investment in Jane according to its last MD&A.
Pender Ventures’ biggest standouts to date have been BC tech stars Jane App, which offers a practice management platform for health and wellness practitioners, and Copperleaf, which sells enterprise decision analytics software to companies managing critical infrastructure.
Prior to joining Pender Ventures, Pacella led one of the earliest investments into Copperleaf during her time with GrowthWorks Capital and later bought into the company in 2019 through Pender Ventures ahead of its 2021 IPO. Pender Ventures also became an early investor in Jane in 2019.
RELATED: Jane App co-founder reveals company’s centaur status at BetaKit Town Hall: Vancouver
Jane, which has raised less than $10 million in primary capital to date, recently became a centaur after hitting $100 million in annual recurring revenue, while Copperleaf went public in 2021 at a more than $1-billion valuation before returning to private markets earlier this year in a $1-billion deal.
Pender Ventures closes second B2B software, healthtech-focused VC fund at $100 million | BetaKit